Author Attribution Corrected in ERIC CLL Study on t(14;19)
A correction has been issued for the ERIC study on chronic lymphocytic leukemia harboring t(14;19), and the change is narrowly focused but important: Arnon Kater’s name had been written incorrectly and now appears as Arnon P. Kater. The original article has been updated accordingly.
A single-letter or initial error can seem minor on the page, yet authorship accuracy carries real weight in a field built on multicenter collaboration, molecular annotation, and traceable expertise. In hematologic oncology, where large consortia often span multiple countries and institutions, the author line is not cosmetic. It anchors credit, accountability, citation integrity, and the permanent scientific record tied to a specific dataset or translational analysis.
For readers tracking the original study on patients with CLL and the rare t(14;19) rearrangement, the correction does not alter the biology, cohort, or any clinical interpretation. It does, however, cleanly restore the identity of one contributor in a paper that sits within a dense collaborative network of hematologists, molecular biologists, genomic scientists, and clinical investigators. In a study spanning ERIC participation, precision in names matters because these papers are often cited repeatedly in research planning, molecular classification work, and future registry comparisons.
Accurate naming also matters to the practical mechanics of academic medicine. Searchable author records influence how work is indexed, how contributions are counted, and how readers link a person to a specific scientific theme over time. When an author’s name is corrected from Kater A to Kater AP, the correction reaches beyond a typographic issue and into the machinery that determines whether a publication is discoverable under the right investigator profile. For a cooperative group publication, that is not trivial.
The update is especially relevant in translational leukemia research, where authorship records often become part of the evidence trail for subsequent papers, abstract submissions, and laboratory-clinic crossovers. In that setting, even a small formatting error can fracture the continuity of a researcher’s publication history. Correcting the record preserves the paper’s bibliographic precision and keeps the article aligned with the rest of the author’s published work.
The correction also reflects the editorial responsibility that sits alongside scientific reporting. Large studies in hematologic malignancies rely on exact attribution because the clinical and transcriptomic data they generate are usually built from contributions at multiple sites, each with its own specialized expertise. When that collaboration is represented in print, the names attached to the work become part of the evidence itself: who generated the dataset, who supervised the analysis, and who carries responsibility for the conclusions.
That may sound administrative, but in academic hematology the administrative layer is part of the science. Multicenter studies are judged not only by what they find, but by the fidelity of the record around those findings. A corrected author name may not change a gene expression pattern or a diagnostic subclassification, yet it does protect the reliability of the publication trail that future investigators depend on when they revisit rare cytogenetic subsets such as t(14;19).
The notice leaves the substantive article untouched. No new patient data, no revised clinical endpoints, and no amended molecular interpretation accompany the correction. The only change is the restoration of the proper form of one author’s name, and that narrow edit is the entire point. Scientific publishing depends on this kind of exactness, especially in areas like leukemia genomics where each paper may inform later cohort definitions, mechanistic hypotheses, or institutional expertise statements.
For clinicians and researchers reading the original ERIC study, the practical instruction is simple: cite the corrected version and recognize the updated author listing. In a field where precision is expected in the laboratory, in the clinic, and in publication metadata, the correction brings the paper back into full alignment with that standard. The data remain the same; the attribution now does too.